Operating

Impairment Charges

McKesson Impairment Charges decreased by 97.7% to $2.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $3.00M to $2.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2014
Last reportedQ1 2026Aug 6, 2025

How to read this metric

An increase signals potential operational issues, poor past investment decisions, or adverse market conditions for specific business units.

Detailed definition

These are non-cash charges recorded when the carrying value of an asset exceeds its fair market value. They indicate tha...

Peer comparison

Often seen during restructuring or economic downturns across industrial sectors.

Metric ID: impairment_charges_cf

Historical Data

15 periods
 Q1 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$104.00M$2.00M$162.00M$0.00$28.00M$0.00$44.00M$28.00M$48.00M$7.00M$3.00M$1.00M$6.00M$88.00M$2.00M
QoQ Change-98.1%>999%-100.0%-100.0%-36.4%+71.4%-85.4%-57.1%-66.7%+500.0%>999%-97.7%
YoY Change-100.0%-100.0%-72.8%+71.4%-89.3%-97.9%-14.3%-33.3%
Range$0.00$162.00M
CAGR-67.7%
Avg YoY Growth-54.5%
Median YoY Growth-81.1%

Business Segments

View all
SegmentQ1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24
International$175.00M$175.00M$175.00M$175.00M$175.00M$175.00M$175.00M$175.00M
Total$0.00$28.00M$0.00$44.00M$28.00M$48.00M$7.00M

International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is McKesson's impairment charges?
McKesson (MCK) reported impairment charges of $2.00M in Q2 2025.
How has McKesson's impairment charges changed year-over-year?
McKesson's impairment charges decreased by 33.3% year-over-year, from $3.00M to $2.00M.
What does impairment charges mean?
A write-down of an asset's value because it is worth less than what is recorded on the balance sheet.